The US Food and Drug Administration has approved the first recombinant coagulation Factor IX product for the prophylaxis of bleeding in people with haemophilia B. The manufacturer is Baxter Healthcare Corporation. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
